New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003.

[1]  D. Stablein,et al.  Posttransplant diabetes mellitus in pediatric renal transplant recipients: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). , 1998, Transplantation.

[2]  J. Najarian,et al.  THE IMPACT OF CYCLOSPORINE AND COMBINATION IMMUNOSUPPRESSION ON THE INCIDENCE OF POSTTRANSPLANT DIABETES IN RENAL ALLOGRAFT RECIPIENTS , 1987, Transplantation.

[3]  F. Cosio,et al.  Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years. , 2001, Kidney international.

[4]  A. Kitabchi,et al.  Hyperglycemic crises in patients with diabetes mellitus. , 2003, Diabetes care.

[5]  Joshua Miller,et al.  A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years. , 2002, Transplantation.

[6]  M. Feinglos,et al.  Oral agents in the management of type 2 diabetes mellitus. , 2001, American family physician.

[7]  C. Lamendola,et al.  Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group IV: lifestyle and medical management of risk factors. , 2002, Circulation.

[8]  J. Fang,et al.  Diabetes mellitus after renal transplantation. , 1998, Transplantation proceedings.

[9]  J. Neylan.  Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group. , 1998, Transplantation.

[10]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[11]  S. Nitter‐Hauge,et al.  Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men. , 1999, Diabetes care.

[12]  E. Barrett-Connor,et al.  Isolated Postchallenge Hyperglycemia and the Risk of Fatal Cardiovascular Disease in Older Women and Men: The Rancho Bernardo Study , 1998, Diabetes Care.

[13]  D. Cohen,et al.  Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus. , 2002, Journal of the American Society of Nephrology : JASN.

[14]  J. Hermans,et al.  Late prednisone withdrawal in cyclosporine-treated kidney transplant patients: a randomized study. , 1997, Journal of the American Society of Nephrology : JASN.

[15]  S. Grundy,et al.  Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. , 1999, Circulation.

[16]  J. Hjelmesaeth,et al.  Impact and management of posttransplant diabetes mellitus. , 2000, Transplantation.

[17]  M. Walker,et al.  Genetics of type 2 diabetes and insulin resistance: knowledge from human studies , 2002, Clinical endocrinology.

[18]  J. Neaton,et al.  Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial , 1993, Diabetes Care.

[19]  H. Fritsche,et al.  Toxicities of tacrolimus and cyclosporin A after allogeneic blood stem cell transplantation , 1997, Bone Marrow Transplantation.

[20]  A Sekikawa,et al.  Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. , 1999, Diabetes care.

[21]  P. Lang,et al.  Diabetes mellitus after renal transplantation: characteristics, outcome, and risk factors. , 1996, Transplantation.

[22]  M. Laakso,et al.  Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. , 1998, Circulation.

[23]  A. Rubin,et al.  HLA-A28 and steroid-induced diabetes in renal transplant patients. , 1980, JAMA.

[24]  R. Stratta,et al.  Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure. , 2003, American Journal of Kidney Diseases.

[25]  G. Burke,et al.  POSTTRANSPLANT HYPERGLYCEMIA: Increased Incidence in Cyclosporine‐Treated Renal Allograft Recipients“ , 1989, Transplantation.

[26]  S. Wallenstein,et al.  Higher incidence of diabetes in liver transplant recipients with hepatitis C. , 1998, Journal of clinical gastroenterology.

[27]  H. King,et al.  Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections , 1998, Diabetes Care.

[28]  J. Ehrich,et al.  Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation , 2002, Pediatric Nephrology.

[29]  B. Kasiske,et al.  Explained and unexplained ischemic heart disease risk after renal transplantation. , 2000, Journal of the American Society of Nephrology : JASN.

[30]  B. Depczynski,et al.  Predicting the occurrence of diabetes mellitus in recipients of heart transplants , 2000, Diabetic medicine : a journal of the British Diabetic Association.

[31]  T. Egeland,et al.  Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age. , 1997, Transplantation.

[32]  P. Marchetti.  Strategies for risk reduction and management of posttransplant diabetes mellitus. , 2001, Transplantation proceedings.

[33]  Norman Fleischer,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. , 1993 .

[34]  G. Dagenais,et al.  Hyperinsulinemia as an independent risk factor for ischemic heart disease. , 1996, The New England journal of medicine.

[35]  M. Hanefeld,et al.  Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up , 1996, Diabetologia.

[36]  U. Settmacher,et al.  Liver transplantation and diabetes mellitus. , 2000, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[37]  E. Friedman,et al.  Posttransplant diabetes in kidney transplant recipients. , 1985, American journal of nephrology.

[38]  D Talbot,et al.  Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group. , 1997, Transplantation.

[39]  T. Greene,et al.  Blood Pressure Control, Proteinuria, and the Progression of Renal Disease , 1995, Annals of Internal Medicine.

[40]  E. Friedman,et al.  Diabetes mellitus after renal transplantation in the cyclosporine era--an analysis of risk factors. , 1991, Transplantation.

[41]  E. Salido,et al.  Regression of left ventricular hypertrophy by lisinopril after renal transplantation: role of ACE gene polymorphism. , 2000, Kidney international.

[42]  M. Schnitzler,et al.  Incidence and Cost of New Onset Diabetes Mellitus Among U.S. Wait‐Listed and Transplanted Renal Allograft Recipients , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[43]  A. Penfornis,et al.  Natural history, prognosis, and management of transplantation-induced diabetes mellitus. , 2002, Diabetes & metabolism.

[44]  A. Hartmann,et al.  Risk factors and incidence of posttransplant diabetes mellitus. , 2001, Transplantation proceedings.

[45]  J. Fink,et al.  Risk for posttransplant Diabetes mellitus with current immunosuppressive medications. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[46]  E. Antman,et al.  ACC/AHA PRACTICE GUIDELINES ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary , 2002 .

[47]  P. Raskin,et al.  Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.

[48]  G A Knoll,et al.  Tacrolimus versus cyclosporin for immunosuppression in renal transplantation: meta-analysis of randomised trials , 1999, BMJ.

[49]  S. Haffner.  Management of Dyslipidemia in Adults With Diabetes , 1998, Diabetes Care.

[50]  A. Jardine,et al.  Influence of diabetes mellitus on patient and graft survival in recipients of kidney transplantation , 2001, Clinical transplantation.

[51]  T. Egeland,et al.  Tapering off prednisolone and cyclosporin the first year after renal transplantation: the effect on glucose tolerance. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[52]  Beverley Balkau,et al.  High Blood Glucose Concentration Is a Risk Factor for Mortality in Middle-Aged Nondiabetic Men: 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study , 1998, Diabetes Care.

[53]  D. Glidden,et al.  Increased incidence in post-transplant diabetes mellitus in children: a case-control analysis , 2002, Pediatric Nephrology.

[54]  M. Christiaans,et al.  Weight changes after renal transplantation: a comparison between patients on 5-mg maintenance steroid therapy and those on steroid-free immunosuppressive therapy , 2003, Transplant international : official journal of the European Society for Organ Transplantation.

[55]  S. Grundy,et al.  Prevention Conference VI: Diabetes and Cardiovascular Disease: Executive Summary Conference Proceeding for Healthcare Professionals From a Special Writing Group of the American Heart Association , 2002, Circulation.

[56]  POSTTRANSPLANT DIABETES MELLITUS IN PEDIATRIC THORACIC ORGAN RECIPIENTS RECEIVING TACROLIMUS-BASED IMMUNOSUPPRESSION1 , 2001, Transplantation.

[57]  D. F. Roberts,et al.  Age at menarche. , 1994, The Lancet.

[58]  P. Arner,et al.  Some Characteristics of Steroid Diabetes: A Study in Renal-Transplant Recipients Receiving High-Dose Corticosteroid Therapy , 1983, Diabetes Care.

[59]  D. Hricik,et al.  Effects of steroid withdrawal on posttransplant diabetes mellitus in cyclosporine-treated renal transplant recipients. , 1991, Transplantation.

[60]  J. Holmes,et al.  FACTORS IN SUCCESSFUL RENAL TRANSPLANTATION. , 1964, Surgery.

[61]  T. Fishbein,et al.  Treatment of tacrolimus-related adverse effects by conversion to cyclosporine in liver transplant recipients , 2000, Transplant international : official journal of the European Society for Organ Transplantation.

[62]  C. Mathieu,et al.  Posttransplantation diabetes mellitus in FK-506-treated renal transplant recipients: analysis of incidence and risk factors. , 2001, Transplantation.

[63]  A. Reuben.  Long‐term management of the liver transplant patient: Diabetes, hyperlipidemia, and obesity , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[64]  J. Shaw,et al.  Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality , 1999, Diabetologia.

[65]  P. Thuluvath,et al.  Outcome of patients with new‐onset diabetes mellitus after liver transplantation compared with those without diabetes mellitus , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[66]  A. Jaffe,et al.  Letters to the editor Reply , 1989 .

[67]  B. Kasiske,et al.  Cardiovascular disease after renal transplantation. , 2000, Journal of the American Society of Nephrology : JASN.

[68]  R. Wolfe,et al.  Long-term survival in renal transplant recipients with graft function. , 2000, Kidney international.

[69]  H. Mcgill,et al.  Determinants of atherosclerosis in the young , 1998 .

[70]  S. Gabriel,et al.  Posttransplantation diabetes: a systematic review of the literature. , 2002, Diabetes care.

[71]  Lawrence A Leiter,et al.  1998 clinical practice guidelines for the management of diabetes in Canada. Canadian Diabetes Association. , 1998, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[72]  R. Chung,et al.  POSTTRANSPLANT DIABETES MELLITUS IN LIVER TRANSPLANT RECIPIENTS: RISK FACTORS, TEMPORAL RELATIONSHIP WITH HEPATITIS C VIRUS ALLOGRAFT HEPATITIS, AND IMPACT ON MORTALITY1 , 2001, Transplantation.

[73]  A. Jaffe,et al.  The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group. , 1989, Journal of the American College of Cardiology.

[74]  M. Harris.  Impaired Glucose Tolerance in the U. S. Population , 1989, Diabetes Care.

[75]  Joshua Miller,et al.  A Comparison Of Tacrolimus (fk506) And Cyclosporine For Immunosuppression After Cadaveric Renal Transplantation1 , 1997 .

[76]  Bertram L Kasiske,et al.  Diabetes Mellitus after Kidney Transplantation in the United States , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[77]  N. Persson,et al.  ISCHEMIC HEART DISEASE—MAJOR CAUSE OF DEATH AND GRAFT LOSS AFTER RENAL TRANSPLANTATION IN SCANDINAVIA , 1995, Transplantation.

[78]  G. Beck,et al.  The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease , 1994 .

[79]  D. Singer,et al.  Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. , 2000, JAMA.

[80]  Detection.  The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) , 1997 .

[81]  E. Friedman,et al.  Diabetes mellitus after renal transplantation: as deleterious as non-transplant-associated diabetes? , 1998, Transplantation.

[82]  F. Cosio,et al.  Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. , 2002, Kidney international.

[83]  B. Suwelack,et al.  Comparison of quinapril versus atenolol: effects on blood pressure and cardiac mass after renal transplantation. , 2000, The American journal of cardiology.

[84]  P. Rabbitt,et al.  Long-term postoperative cognitive dysfunction in the elderly: ISPOCD1 study , 1998, The Lancet.

[85]  E. Feskens,et al.  Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria , 1999, The Lancet.

[86]  P. Raskin,et al.  Treatment of hypertension in adults with diabetes. , 2003 .

[87]  D. Singer,et al.  Diabetic Myocardial Infarction: Interaction of Diabetes With Other Preinfarction Risk Factors , 1989, Diabetes.

[88]  J. Briegel,et al.  Tacrolismus (FK506) as Primary Immunosuppressant After Lung Transplantation , 1999 .

[89]  D. Levy,et al.  Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.

[90]  R. Foley,et al.  Clinical epidemiology of cardiovascular disease in chronic renal disease. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[91]  M. Markell.  Clinical impact of posttransplant diabetes mellitus. , 2001, Transplantation proceedings.

[92]  G. Wilson,et al.  Obesity as a risk factor after combined pancreas/kidney transplantation. , 1995, Transplantation.